Ernexa Therapeutics Inc.

ERNANasdaqCIK 748592HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 422 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Ernexa Therapeutics Inc., Reports and events
Filed	Form	What it is	Accession number
2015-04-1608:40 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001019687-15-001484
2015-03-2714:29 ET	10-K	Annual reportPeriod 2014-12-31	0001019687-15-001115
2015-03-2616:05 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-15-001096
2015-03-1011:01 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001019687-15-000887
2014-12-1908:35 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001019687-14-004766
2014-11-0716:15 ET	10-Q	Quarterly reportPeriod 2014-09-30	0001019687-14-004114
2014-11-0616:10 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-14-004086
2014-09-2912:30 ET	8-K	5.02 Departure or appointment of officers or directors	0001019687-14-003725
2014-09-1620:22 ET	8-K	5.02 Departure or appointment of officers or directors	0001019687-14-003609
2014-09-0913:11 ET	8-K	9.01 Financial statements and exhibits	0001019687-14-003514
2014-08-2217:14 ET	8-K	5.02 Departure or appointment of officers or directors	0001019687-14-003354
2014-08-1414:44 ET	10-Q	Quarterly reportPeriod 2014-06-30	0001019687-14-003169
2014-08-1316:21 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-14-003099
2014-06-1016:37 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits	0001019687-14-002383
2014-05-1516:24 ET	10-Q	Quarterly reportPeriod 2014-03-31	0001019687-14-001956
2014-05-1416:20 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-14-001852
2014-04-2516:09 ET	DEF 14A	Proxy statementPeriod 2014-06-06	0001019687-14-001539
2014-04-2117:25 ET	SC 13D/A	Ownership report, active investor, amended	0001019687-14-001492
2014-04-1717:18 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001019687-14-001469
2014-04-1611:05 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001019687-14-001447
2014-04-1108:30 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001019687-14-001343
2014-03-3116:14 ET	10-K	Annual reportPeriod 2013-12-31	0001019687-14-001135
2014-03-2716:33 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-14-001038
2014-03-1412:44 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001019687-14-000832
2014-01-2717:24 ET	8-K	5.02 Departure or appointment of officers or directors	0001019687-14-000271
2014-01-0617:15 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001019687-14-000045
2013-12-0915:11 ET	8-K	4.01 Change of auditor; 9.01 Financial statements and exhibits	0001019687-13-004756
2013-11-2214:44 ET	8-K	7.01 Regulation FD disclosure	0001019687-13-004605
2013-11-1414:14 ET	10-Q	Quarterly reportPeriod 2013-09-30	0001019687-13-004331
2013-11-1316:26 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits	0001019687-13-004257
2013-11-1316:25 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-13-004256
2013-08-1417:48 ET	10-Q	Quarterly reportPeriod 2013-06-30	0001019687-13-003135
2013-08-1417:47 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-13-003136
2013-06-1316:44 ET	8-K/A	5.07 Shareholder vote results	0001019687-13-002331
2013-06-1117:26 ET	8-K	5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001019687-13-002314
2013-05-1315:33 ET	10-Q	Quarterly reportPeriod 2013-03-31	0001019687-13-001786
2013-05-0916:20 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-13-001708
2013-04-2613:16 ET	DEF 14A	Proxy statementPeriod 2013-06-07	0001019687-13-001510
2013-03-2915:37 ET	10-K	Annual reportPeriod 2012-12-31	0001019687-13-001065
2013-03-2816:25 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-13-001030
2013-03-2108:11 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001019687-13-000909
2013-02-0616:57 ET	SC 13D/A	Ownership report, active investor, amended	0001144204-13-006496
2013-01-1516:39 ET	8-K	5.02 Departure or appointment of officers or directors	0001019687-13-000153
2012-12-2820:03 ET	SC 13D/A	Ownership report, active investor, amended	0001019687-12-004663
2012-11-0913:49 ET	10-Q	Quarterly reportPeriod 2012-09-30	0001019687-12-003931
2012-11-0816:20 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-12-003919
2012-09-1306:03 ET	SC 13D/A	Ownership report, active investor, amended	0001019687-12-003344
2012-08-1413:43 ET	10-Q	Quarterly reportPeriod 2012-06-30	0001019687-12-002787
2012-08-1317:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001019687-12-002743
2012-07-0916:40 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001019687-12-002364

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.